ArticleJournal of computer-aided molecular design2026
Advances in the application of molecular docking in nanomedicine.
Article in Journal of computer-aided molecular design, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Molecular docking, a relatively well-established research instrument, is extensively applied in protein research and drug development. Recently, the technique has also exerted a vital role in nanomedicine research, especially in nanotechnology-based drug design and delivery system research. However, so far no one has sorted out the current situation of this interdisciplinary field. In this review, firstly, the basic principles and methods of molecular docking were introduced; then several specific applications were highlighted in the context of nanomedicine re-search, including nanomaterial modification, screening of nanomedicine carriers, screening (validation) of potential ligands (targets) of nanomaterials, and assessment of the toxicity or biosafety of nanomaterials were summarized; finally, the current challenges of molecular docking in nanomedicine re-search were discussed, and an outlook on its development and optimization was also given. This work is expected to make it easier for researchers to comprehend molecular docking and its applications in nanomedicine.
Indexed as
Identifiers
41772188What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.